Cullinan Oncology

Cullinan Oncology

Cullinan Oncology

Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research.
Founded
2017
Raised
$248.5M
Follow us
Alexa global traffic share
Latest funding
$98,500,000
Venture capital (Series B) - 2020
MPM Capital F2 Ventures
$150,000,000
Series A - 2017
MPM Capital F2 Ventures
Team Size
2
Employees
Xconomy

Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline

$98,500,000 Venture capital (Series B)
FinSMEs

Cullinan Oncology Closes $98.5M Series B Financing Round